TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 79 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,335,000 | -8.1% | 18,100 | -8.5% | 0.00% | 0.0% |
| Q4 2020 | $1,452,000 | +31.2% | 19,774 | -2.0% | 0.00% | 0.0% |
| Q3 2020 | $1,107,000 | -14.9% | 20,174 | +3.1% | 0.00% | 0.0% |
| Q2 2020 | $1,301,000 | -14.6% | 19,574 | -21.3% | 0.00% | -50.0% |
| Q1 2020 | $1,523,000 | -47.4% | 24,881 | -24.5% | 0.00% | -33.3% |
| Q4 2019 | $2,897,000 | -7.8% | 32,941 | -20.9% | 0.00% | 0.0% |
| Q3 2019 | $3,141,000 | +2.2% | 41,626 | +15.7% | 0.00% | -25.0% |
| Q2 2019 | $3,074,000 | -36.7% | 35,984 | -19.9% | 0.00% | -33.3% |
| Q1 2019 | $4,855,000 | +45.4% | 44,916 | +13.9% | 0.01% | +20.0% |
| Q4 2018 | $3,338,000 | -24.5% | 39,443 | -12.3% | 0.01% | -16.7% |
| Q3 2018 | $4,420,000 | +3.6% | 44,968 | +22.0% | 0.01% | 0.0% |
| Q2 2018 | $4,265,000 | +26.1% | 36,869 | +7.6% | 0.01% | +20.0% |
| Q1 2018 | $3,383,000 | +4.3% | 34,258 | +10.6% | 0.01% | +25.0% |
| Q4 2017 | $3,242,000 | -15.0% | 30,961 | -8.5% | 0.00% | -33.3% |
| Q3 2017 | $3,815,000 | +3.8% | 33,851 | +3.2% | 0.01% | 0.0% |
| Q2 2017 | $3,676,000 | -2.1% | 32,800 | +1.9% | 0.01% | 0.0% |
| Q1 2017 | $3,755,000 | +16.6% | 32,200 | +5.2% | 0.01% | +20.0% |
| Q4 2016 | $3,221,000 | -25.5% | 30,600 | -21.7% | 0.01% | -28.6% |
| Q3 2016 | $4,321,000 | -27.6% | 39,100 | -4.6% | 0.01% | -30.0% |
| Q2 2016 | $5,970,000 | +7.4% | 41,000 | +5.7% | 0.01% | +11.1% |
| Q1 2016 | $5,558,000 | -12.7% | 38,800 | -5.8% | 0.01% | -10.0% |
| Q4 2015 | $6,367,000 | +8.7% | 41,200 | +0.5% | 0.01% | 0.0% |
| Q3 2015 | $5,858,000 | -16.5% | 41,000 | -16.0% | 0.01% | -9.1% |
| Q2 2015 | $7,012,000 | -11.1% | 48,800 | +0.8% | 0.01% | 0.0% |
| Q1 2015 | $7,887,000 | 0.0% | 48,400 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $7,887,000 | +16.5% | 48,400 | +10.0% | 0.01% | +22.2% |
| Q3 2014 | $6,770,000 | +20.7% | 44,000 | +10.0% | 0.01% | +12.5% |
| Q2 2014 | $5,610,000 | +25.8% | 40,000 | -1.7% | 0.01% | +33.3% |
| Q1 2014 | $4,458,000 | +149.9% | 40,700 | +124.9% | 0.01% | +100.0% |
| Q4 2013 | $1,784,000 | +32.6% | 18,100 | +2.3% | 0.00% | +50.0% |
| Q3 2013 | $1,345,000 | +63.8% | 17,700 | +20.5% | 0.00% | 0.0% |
| Q2 2013 | $821,000 | – | 14,692 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 545,583 | $34,715,000 | 10.89% |
| Murchinson Ltd. | 100,000 | $6,363,000 | 3.16% |
| Eversept Partners, LP | 179,366 | $11,413,059 | 0.79% |
| BRANDES INVESTMENT PARTNERS, LP | 266,560 | $16,962,000 | 0.37% |
| Analyst IMS Investment Management Services Ltd. | 22,755 | $1,447,000 | 0.18% |
| Claret Asset Management Corp | 9,336 | $594,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 344,023 | $21,851,000 | 0.08% |
| Renaissance Technologies | 720,500 | $45,845,000 | 0.06% |
| C M BIDWELL & ASSOCIATES LTD | 1,155 | $73,000 | 0.05% |
| First Trust Direct Indexing L.P. | 3,357 | $214,000 | 0.03% |